Finance

Lists
REC:BIT
Recordati Industria Chmc Frmctc SpA
53,00 €
0,00%
(0,00) 1D
30 հոկ, 17:35:18 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for REC...
Open
53,00 €
High
53,05 €
Low
52,95 €
Mkt. cap
11,08 մլրդ
Avg. vol.
400,03 հզր
Volume
240,54 հզր
Dividend
2,53%
Quarterly dividend
0,34 €
Ex-dividend date
18 մյս, 2026 թ.
P/E ratio
21,78
52-wk high
54,45 €
52-wk low
43,76 €
EPS
2,43 €
Shares outstanding
203,77 մլն
No. of employees
5 հզր
Open
53,00 €
High
53,05 €
Low
52,95 €
Mkt. cap
11,08 մլրդ
Avg. vol.
400,03 հզր
Volume
240,54 հզր
Dividend
2,53%
Quarterly dividend
0,34 €
Ex-dividend date
18 մյս, 2026 թ.
P/E ratio
21,78
52-wk high
54,45 €
52-wk low
43,76 €
EPS
2,43 €
Shares outstanding
203,77 մլն
No. of employees
5 հզր
News stories
From web sources and news partners
Profile
Recordati Industria Chimica e Farmaceutica S.p.A., known as Recordati, is an Italian pharmaceutical company based in Milan. It was founded in Correggio in 1926 by Giovanni Recordati, whose family ran a pharmacy in the town, and moved to Milan in 1953. The company has been listed on the Borsa Italiana since 1984. Since 2018 it has been controlled by the private equity firm CVC Capital Partners, which in 2026 made a tender offer with Groupe Bruxelles Lambert to take it off the stock exchange. Wikipedia
About Recordati Industria Chmc Frmctc SpA
CEORobert Koremans
Employees4,65 հզր
Founded1926
Headquarters-
Sector-
Next call 10 օրից
նոյ 11, չրք, 15:00
Fiscal period
Q3 2026
- / 0,79 €
Revenue / Est. (EUR)
- / 674,40 մլն
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
632,32 մլն
662,22 մլն
713,42 մլն
697,36 մլն
Cost of goods sold
199,91 մլն
122,80 մլն
202,60 մլն
199,38 մլն
Cost of revenue
199,91 մլն
122,80 մլն
202,60 մլն
199,38 մլն
Research and development expenses
79,81 մլն
94,02 մլն
86,34 մլն
92,71 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
171,45 մլն
187,37 մլն
192,84 մլն
201,67 մլն
Operating expense
265,70 մլն
269,50 մլն
279,80 մլն
294,37 մլն
Total operating expenses
465,61 մլն
392,31 մլն
482,40 մլն
493,75 մլն
Operating income
166,71 մլն
269,91 մլն
231,03 մլն
203,61 մլն
Other non operating income
-
-
-
-
EBT including unusual items
144,95 մլն
151,97 մլն
200,75 մլն
161,16 մլն
EBT excluding unusual items
148,07 մլն
248,68 մլն
204,26 մլն
176,23 մլն
Income tax expense
34,78 մլն
34,64 մլն
47,69 մլն
44,54 մլն
Effective tax rate
24,00%
22,79%
23,76%
27,64%
Other operating expenses
14,43 մլն
-11,89 մլն
615,00 հզր
-16,00 հզր
Net income
110,16 մլն
117,34 մլն
153,06 մլն
116,61 մլն
Net profit margin
17,42%
17,72%
21,45%
16,72%
Earnings per share
0,79
0,76
0,90
-
Interest and investment income
470,00 հզր
-
-
-
Interest expense
-22,60 մլն
-25,26 մլն
-24,91 մլն
-25,02 մլն
Net interest expenses
-22,13 մլն
-25,26 մլն
-24,91 մլն
-25,02 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
214,47 մլն
320,11 մլն
280,06 մլն
253,20 մլն
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps